Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2011 Mar 09;3110:3650-61. doi: 10.1523/JNEUROSCI.5565-10.2011.
Show Gene links
Show Anatomy links
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
Hansen KB, Traynelis SF.
???displayArticle.abstract???
NMDA receptors are ionotropic glutamate receptors that mediate excitatory synaptic transmission and have been implicated in several neurological diseases. We have evaluated the mechanism of action of a class of novel subunit-selective NMDA receptor antagonists, typified by (E)-4-(6-methoxy-2-(3-nitrostyryl)-4-oxoquinazolin-3(4H)-yl)-benzoic acid (QNZ46). We found that QNZ46 inhibits NMDA receptor function in a noncompetitive and voltage-independent manner by an unconventional mechanism that requires binding of glutamate to the GluN2 subunit, but not glycine binding to the GluN1 subunit. This dependency of antagonist association on glutamate binding to GluN2 renders these compounds nominally use-dependent, since inhibition will rely on synaptic release of glutamate. Evaluation of the structural determinants responsible for the subunit-selectivity of QNZ46 revealed that these compounds act at a new site that has not previously been described. Residues residing in the part of the agonist binding domain immediately adjacent to the transmembrane helices appear to control selectivity of QNZ46 for GluN2C- and GluN2D-containing receptors. These residues are well-positioned to sense glutamate binding to GluN2 and thus to mediate glutamate-dependent actions. This new class of noncompetitive antagonists could provide an opportunity for the development of pharmacological tools and therapeutic agents that target NMDA receptors at a new site and modulate function by a novel mechanism.
Balannik,
Molecular mechanism of AMPA receptor noncompetitive antagonism.
2005,
Pubmed
,
Xenbase Costa,
A novel family of negative and positive allosteric modulators of NMDA receptors.
2010,
Pubmed
,
Xenbase Eswar,
Protein structure modeling with MODELLER.
2008,
Pubmed Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed Horak,
Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
2006,
Pubmed Ishii,
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
1993,
Pubmed
,
Xenbase Jang,
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity.
2004,
Pubmed
,
Xenbase Kalia,
NMDA receptors in clinical neurology: excitatory times ahead.
2008,
Pubmed Kleckner,
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase Kuntal,
EasyModeller: A graphical interface to MODELLER.
2010,
Pubmed Kussius,
Pregnanolone sulfate promotes desensitization of activated NMDA receptors.
2009,
Pubmed Lazzaro,
Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist.
2002,
Pubmed Menniti,
CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
2003,
Pubmed Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed Monyer,
Heteromeric NMDA receptors: molecular and functional distinction of subtypes.
1992,
Pubmed Mosley,
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
2010,
Pubmed
,
Xenbase Petrovic,
20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor.
2005,
Pubmed Prieto,
Gating modes in AMPA receptors.
2010,
Pubmed Robert,
How AMPA receptor desensitization depends on receptor occupancy.
2003,
Pubmed Rosenmund,
The tetrameric structure of a glutamate receptor channel.
1998,
Pubmed Sobolevsky,
Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating.
2007,
Pubmed
,
Xenbase Sobolevsky,
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor.
2009,
Pubmed Talukder,
Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating.
2010,
Pubmed
,
Xenbase Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase Ulbrich,
Subunit counting in membrane-bound proteins.
2007,
Pubmed
,
Xenbase Vicini,
Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
1998,
Pubmed Watanabe,
Distinct spatio-temporal distributions of the NMDA receptor channel subunit mRNAs in the brain.
1993,
Pubmed Welch,
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
2001,
Pubmed Wo,
Unraveling the modular design of glutamate-gated ion channels.
1995,
Pubmed Yuan,
Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
2009,
Pubmed
,
Xenbase
